Expression of p53 and p21 proteins in opal squamous cell carcinoma: Correlation with lymph node metastasis and response to chemoradiotherapy

Pathology Research and Practice

Volumn 194, Issue 12, 1998, Pages 821-830

  Tatemoto, Y ^a   Osaki, T ^a   Yoneda, K ^a   Yamamoto, T ^a   Ueta, E ^a   Kimura, T ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Chemoradiotherapy; Metastasis; Oral squamous cell carcinoma; p21; p53

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR; FLUOROURACIL; PEPLEOMYCIN; PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; COBALT THERAPY; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MULTIMODALITY CANCER THERAPY; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SUBCUTANEOUS DRUG ADMINISTRATION; SUPPRESSOR GENE;

EID: 0032423632     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(98)80084-8     Document Type: Article

References (58)

1. JC Ahomadegbe M Barrois S Fogel ML Le Bihan S Douc-Rasy P Duvillard JP Armand G Riou High incidence of p53 alteration (mutation, deletion, overexpression) in head and neck primary tumors and metastasis; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions Oncogene 10 1995 1217 1227
2. IO Baas J-WR Mulder JA Offerhaus B Vogelstein SR Hamilton An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms J Pathol 172 1994 5 12
3. WAF1 immunohistochemical expression in breast carcinoma: correlations with clinico-pathological data, oestrogen receptor status, MIB expression, p53 gene and protein alterations and relapse-free survival Br J Cancer 74 1996 208 215
4. WAF1 is heterogenous and unrelated to proliferation index in human ovarian carcinoma Int J Cancer 63 1995 611 615
5. J Bourhis J Bosq GD Wilson B Bressac M Talbot AM Leridant R Dendale N Janin JP Armand B Luboinski EP Malaise P Wibault F Eschwege Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer Int J Cancer 57 1994 458 462
6. L Buckbinder R Talbott S Valasco-Miguel I Takenaka B Faha BR Seizinger N Kley Induction of the growth inhibitor IGF-binding protein 3 by p53-target genes Nature (Lond.) 377 1995 646 649
7. RL Byrne CH Wilson Home MC Robinson P Autzen I Apakama RI Bishop DE Neal FC Hamdy The expression of waf-1, p53 and bcl-2 in prostatic adenocarcinoma Br J Urol 79 1997 190 195
8. wAF1 Cancer Res 55 1995 4536 4537
9. VC De Araujo AM Loyola DD Santos Pinto Jr RC Borra NS De Araujo p53 in biopsies of oral squamous cell carcinoma. A comparative study with a malignancy grading system Oral Oncol 33 1997 5 9
10. WC Dewey CC Ling RE Meyn Radiation-induced apoptosis: relevance to radiotherapy Int J Radiation Oncol Bioi Phys 33 1995 781 796
11. JA DiGiuseppe MS Redston CJ Yeo SE Kern RH Hruban p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma Am J Pathol 147 1995 884 888
12. WS El-Deiry T Tokino VE Velculescu DB Levy R Parsons JM Trent D Lin WE Mercer KW Kinzler B Vogelstein WAFl, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
13. T Furuhara T Tokino T Urano Y Nakamura Isolation of a novel GPI-anchored gene specifically regulated by p53; correlation between its expression and anti-cancer drug sensitivity Oncogene 13 1996 1965 1970
14. PA Hall DP Lane p53 in tumour pathology: can we trust immunohistochemistry ? -revisited ! J Pathol 172 1994 1 4
15. JW Harper GR Adami N Wei K Keyomarsi SJ Elledge The p21 Cdk-interacting protein CIPl is a potent inhibitor of G 1 cyclin-dependent kinases Cell 75 1993 805 816
16. CC Harris M Hollstein Clinical implication of p53 tumor-suppressor gene N Eng J Med 329 1993 1318 1327
17. N Hayashi I Ito A Yanagisawa Y Kato S Nakamori S Imaoka H Watanabe M Ogawa Y Nakamura Genetic diagnosis of lymph-node metastasis in colorectal cancer Lancet 345 1995 1257 1259
18. PA Heinzel P Balaram H-U Bernard Mutations and polymorphisms in the p53, p21, and pl6 genes in oral carcinomas of indian betelquid chewers Int J Cancer 68 1996 420 423
19. JA Hickman Apoptosis induced by anticancer drugs Cancer Metastasis Rev 11 1992 121 139
20. M Hollstein B Shomer M Greenblatt T Soussi E Hovig R Montesano CC Harris Somatic point mutations in the p53 gene of human tumors and cell lines: updated complication Nuc Acids Res 24 1996 141 146
21. M Hozumi Fundamentals of chemo-differentiation therapy of myeloid leukemia Anticancer Res 14 1994 1177 1192
22. MB Kastan Q Zhan WS El-Deiry F Carrier T Jacks WV Walsh BS Plunkett B Vogelstein AJ Pomace Jr A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia Cell 71 1992 587 592
23. JFR Kerr AH Wyllie AR Currie Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 26 1972 239 257
24. S Kuerbitz B Plunkett W Walsh M Kastan Wild type p53 is a cell cycle checkpoint determinant following radiation Nature (Lond.) 89 1992 7491 7495
25. K Kusama S Okutsu K Takeda T Himiya A Kojima Y Kidokoro L Chu S Iwanari I Kodo I Moro p53 gene alteration and p53 protein in oral epithelial dysplasia and squamous cell carcinoma J Pathol 178 1996 415 421
26. DP Lane p53, guardian of the genome Nature (Lond.) 358 1992 15 16
27. MA Levesque D Katsaros H Yu M Giai F Genta R Roagna R Ponzone M Massobrio P Sismondi EP Diamandis Immunofluorometrically determined p53 accumulation as a prognostic indicator in italian breast cancer patients Int J Cancer (Pred Oncol) 79 1998 147 152
28. AJ Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
29. J Lukas S Groshen B Saffari N Niu A Reles W-H Wen J Felix LA Jones FL Hall MF Press WAFl/Cipl gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium Am J Pathol 150 1997 167 175
30. Y Lu N Yamagishi T Yagi H Takebe Mutated p21 (WAFl/Cipl/SDil) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells Oncogene 16 1998 705 712
31. KF Macleod N Sherry G Hannon D Beach T Tokino K Kinzler B Vogelstein T Jacks p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage Genes & Dev 15 1995 935 944
32. WAF1CIPl in malignant melanoma. Reduced expression in metastatic lesions Am J Pathol 149 1996 1813 1822
33. A Marchetti C Doglioni M Barbareschi F Buttitta S Pellegrini G Bertacca A Chella G Merlo CA Angeletti PD Palma G Bevilacqua p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation Oncogene 12 1996 1319 1324
34. T Miyashita JC Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
35. J Momand GP Zambetti DC Olson DL George AJ Levine The MDM oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 69 1992 1237 1245
36. wAFlCipl expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx J Pathol 183 1997 156 163
37. JM Nigro SJ Baker AC Preisinger JM Jessup R Hostetter K Cleary SH Eigner N Davidson S Baylin P Devilee T Glover FC Collins A Weston R Modali CC Harris B Vogelsteip Mutations of p53 gene occur in diverse human tumour types Nature (Lond.) 342 1989 705 708
38. K Nylander R Stenling H Gustafsson B Zackrisson G Roos p53 expression and cell proliferation in squamous cell carcinomas of the head and neck Cancer 75 1995 87 93
39. K Okamoto D Bearch CyclinG is a transcriptional target of the p53 tumor suppressor protein EMBO J 13 1994 4816 4822
40. CN Papandreou T Bogenrieder F Loganzo AP Albino DM Nanus Expression and sequence analysis of the p21 (WAFl/Cipl) gene in renal cancers Urology 49 1997 481 486
41. E Sakai N Tsuchida Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumorsuppressor genes Oncogene 7 1992 927 933
42. SR Shi ME Key KL Kalra Antigen retrieval in formalin-fixed, paraffin-embedded tissues; an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections J Histochem Cytochem 39 1991 741 748
43. T Shimosato S Oboshi K Baba Histological evaluation of effects of radiotherapy and chemotherapy of carcinomas Jpn J Clin Oncol 1 1971 19 35
44. R Soong PD Robbins BR Dix F Grieu B Lim S Knowles KE Williams GR Turbett AK House BJ Iacopetta Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas Hum Pathol 27 1996 1050 1055
45. K Sugamura M Makino H Shirai A Kimura M Maeta H Itoh N Kaibara Enhanced induction of apoptosis of human gastric carcinoma cells after preoperative treatment with 5-fluorouracil Cancer 79 1997 12 17
46. CB Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456 1462
47. C Trivedy KAAS Warnakulasuriya M Tabassoli H Steingrimsdottir J Penhallow R Maher NW Johnson p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP J Oral Pathol Med 27 1998 72 77
48. UICC TNM classification of malignant tumours 4th ed. 1987 Springer-Verlag Berlin 16 18
49. DL Vaux Toward a understanding of the molecular mechanisms of physiological cell death Proc Natl Acad Sci USA 90 1993 786 789
50. E Wakasugi T Kobayashi Y Tamaki Y Ito I Miyashiro Y Komoike T Takeda E Shin Y Takatsuka N Kikkawa T Monden M Monden p21 (Wafl/Cipl) and 53 protein expression in breast cancer Am J Clin Pathol 107 1997 684 691
51. T Waldman C Lengauer KW Kinzler B Vogelstein Uncoupling of S phase and mitosis induced by anti cancer agents in cells lacking p21 Nature 381 1996 713 716
52. A Wang N Yoshimi N Ino T Tanaka H Mori WAFl expression and p53 mutations in human colorectal cancers J Cancer Res Clin Oncol 23 1997 118 123
53. RA Weinberg The retinoblastoma protein and cell cycle control Cell 81 1995 323 330
54. AH Wyllie Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview Cancer Metastasis Rev 11 1992 95 103
55. Y Xiong G Hannon H Zhang D Casso R Kobayashi D Bearch p21 is an universal inhibitor or cyclin kinases Nature (Lond.) 366 1993 701 704
56. E Yamamoto G Kohama H Sunakawa M lwai H Hiratsuka Mode of invasion: bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity Cancer 50 1983 2175 2180
57. W Yasui Y Akama H Kuniyasu H Yokozaki S Semba F Shimamoto E Tahara Expression of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: Relationship with p53 status and proliferative activity J Pathol 180 1996 122 128
58. E Yonish-Arouach D Resnitzky J Lotem L Sachs A Kimchi M Oren Wild-type p53 induces apoptosis of myeloid leukaemaic cells that is inhibit by interleukin-6 Nature (Lond.) 352 1991 345 347